BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 43210)

  • 41. [Behavioral and neuropharmacological studies of trioxazin (trimetozine) (author's transl)].
    Gomita Y; Kawasaki H; Fukamachi K; Takasaki K; Urabe M; Yamamoto R; Nakayama K; Kawai Y
    Igaku Kenkyu; 1978 Aug; 48(6):469-87. PubMed ID: 34972
    [No Abstract]   [Full Text] [Related]  

  • 42. Behavioral studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs.
    Simon P; Soubrié P
    Mod Probl Pharmacopsychiatry; 1979; 14():99-143. PubMed ID: 33330
    [No Abstract]   [Full Text] [Related]  

  • 43. Gonadectomy enhances shock-induced behavioral inhibition in adult male rats: implications for impulsive behavior.
    Svensson AI; Söderpalm B; Engel JA
    Pharmacol Biochem Behav; 2000 Apr; 65(4):731-6. PubMed ID: 10764930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benzodiazepines and behavioral effects of reward (water) omission in the rat.
    Soubrié P; Thiébot MH; Simon P; Boissier JR
    Psychopharmacology (Berl); 1978 Sep; 59(1):95-100. PubMed ID: 30110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benzodiazepines and behavior.
    File SE; Cooper SJ
    Neurosci Biobehav Rev; 1985; 9(1):1-3. PubMed ID: 2858074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caffeine-induced hypodipsia in water-deprived rats: relationships with benzodiazepine mechanisms.
    Cooper SJ
    Pharmacol Biochem Behav; 1982 Sep; 17(3):481-7. PubMed ID: 6128742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxide.
    Frye GD; Vogel RA; Mailman RB; Ondrusek MG; Wilson JH; Mueller PA; Breese GR
    Adv Exp Med Biol; 1980; 132():729-37. PubMed ID: 6252770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of acute and chronic alcoholism on the activity of two benzodiazepines: oxazepam and medazepam].
    Bourrinet P; Takeda H
    Ann Pharm Fr; 1976; 34(9-10):361-7. PubMed ID: 13700
    [No Abstract]   [Full Text] [Related]  

  • 49. The main pharmacological characteristics of Grandaxin (tofizopam, EGYT-341).
    Petöcz L; Kosóczky I
    Ther Hung; 1975; 23(4):134-8. PubMed ID: 7851
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of the effects of benzodiazepine and nonbenzodiazepine anxiolytics on mouse-killing behavior in rats.
    Takaoka N; Yoshimura H; Ogawa N
    Jpn J Pharmacol; 1988 Mar; 46(3):315-8. PubMed ID: 2898034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and anxiolytic activity of a series of pyrazino[1,2-a][1,4]benzodiazepine derivatives.
    Smith RG; Lucas RA; Wasley JW
    J Med Chem; 1980 Aug; 23(8):952-5. PubMed ID: 6105221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of benzodiazepine derivatives on cholinesterase activity of rat blood].
    Wiezorek WD; Liebmann H; Stremmel D
    Pharmazie; 1977; 32(8-9):530-2. PubMed ID: 22876
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative structure-activity relationships in minor tranquilizers. Benzodiazepinooxazole derivatives.
    Yoshimoto M; Kamioka T; Miyadera T; Kobayashi S; Takagi H
    Chem Pharm Bull (Tokyo); 1977 Jun; 25(6):1378-90. PubMed ID: 19156
    [No Abstract]   [Full Text] [Related]  

  • 54. Dissociation of the hyperphagic from the anxiolytic effects of benzodiazepines.
    Cooper SJ
    Psychopharmacol Bull; 1979 Jan; 15(1):6. PubMed ID: 33412
    [No Abstract]   [Full Text] [Related]  

  • 55. Behavioural influences on benzodiazepine tolerance: when do they occur and what do they mean?
    Goudie AJ
    Psychopharmacology (Berl); 1988; 95(4):546-9. PubMed ID: 2905504
    [No Abstract]   [Full Text] [Related]  

  • 56. Behavior analysis of the effects and mechanisms of action of benzodiazepines.
    Cook L; Sepinwall J
    Psychopharmacol Bull; 1975 Oct; 11(4):53-5. PubMed ID: 718
    [No Abstract]   [Full Text] [Related]  

  • 57. Psychomotor changes during initial day of benzodiazepine medication.
    Wittenborn JR; Flaherty CF; McGough WE; Nash RJ
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):69S-76S. PubMed ID: 35208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethopharmacological studies of anxiolytics and aggression.
    Olivier B; Mos J; Miczek KA
    Eur Neuropsychopharmacol; 1991 May; 1(2):97-100. PubMed ID: 1687978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure activity relationships of anxiolytics.
    Wong MG
    Drug Des Deliv; 1988 Jul; 3(1):15-33. PubMed ID: 2908225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel peptidoaminobenzophenones, terminal N-substituted peptidoaminobenzophenones, and N-(acylglycyl)aminobenzophenones as open-ring derivatives of benzodiazepines.
    Hirai K; Ishiba T; Sugimoto H; Fujishita T; Tsukinoki Y; Hirose K
    J Med Chem; 1981 Jan; 24(1):20-7. PubMed ID: 6110780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.